Hisamitsu Pharmaceutical Co Inc
F:HPX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hisamitsu Pharmaceutical Co Inc
F:HPX
|
JP |
|
G
|
G2 Energy Corp
F:B4O
|
CA |
|
G
|
Gemfields Group Ltd
XBER:5PH
|
GG |
|
S
|
Sugi Holdings Co Ltd
XMUN:UGI
|
JP |
|
A
|
Akzo Nobel NV
LSE:0A00
|
NL |
|
M
|
Moil Ltd
BSE:533286
|
IN |
|
Steven Madden Ltd
F:SJM
|
US |
|
S
|
Sompo Holdings Inc
XBER:ANK
|
JP |
|
H2O Innovation Inc
F:H3O1
|
CA |
Wall St Price Targets
HPX Price Targets Summary
Hisamitsu Pharmaceutical Co Inc
According to Wall Street analysts, the average 1-year price target for HPX is 16.51 EUR with a low forecast of 16.15 EUR and a high forecast of 17.19 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HPX's stock price target?
Price Target
16.51
EUR
According to Wall Street analysts, the average 1-year price target for HPX is 16.51 EUR with a low forecast of 16.15 EUR and a high forecast of 17.19 EUR.
What is the Revenue forecast for Hisamitsu Pharmaceutical Co Inc?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Hisamitsu Pharmaceutical Co Inc?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Operating Income has been -3%. The projected CAGR for the next 14 years is 2%.
What is the Net Income forecast for Hisamitsu Pharmaceutical Co Inc?
Projected CAGR
3%
Over the last 14 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 3 years is 3%.
